1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Sodium chloride |
| brand | String | Normal saline, NaCl injection, many; nebulized: HyperSal, PulmoSal |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Crystalloid_IV_fluids|Crystalloid IV fluid]] • [[:Category:Electrolyte_replacements|Electrolyte replacement]] |
| mechanism | String | '"`UNIQ--vote-00000037-QINU`"' Hypertonic 3% is the standard urgent treatment of severely symptomatic hyponatremia'"`UNIQ--ref-00000038-QINU`"'. |
| uses | String | '"`UNIQ--vote-00000039-QINU`"', '"`UNIQ--vote-0000003A-QINU`"', '"`UNIQ--vote-0000003B-QINU`"', '"`UNIQ--vote-0000003C-QINU`"', '"`UNIQ--vote-0000003D-QINU`"' |
| starting_dose | String | Volume and concentration titrated to clinical status; symptomatic hyponatremia: 3% NaCl 100-150 mL bolus, reassess |
| preparations | String | 0.225%, 0.45%, 0.9%, 3%, 5% IV solutions; 0.9% nasal spray; 3% and 7% nebulizer solutions; oral tablets (1 g) |
| fda_max | String | No fixed maximum; titrated; sodium correction rate in chronic hyponatremia must not exceed 8-10 mEq/L per 24 hours to avoid osmotic demyelination |
| pill_id | Text | |
| routes | List of String, delimiter: , | IV • oral • nebulized • intranasal • ophthalmic |
| onset | String | Immediate (IV) |
| duration | String | Roughly 20-25% of an IV bolus remains intravascular at 1 hour |
| halflife | String | Not applicable (electrolyte) |
| bioavailability | String | 100% (IV); essentially complete (oral) |
| pregnancy | String | Standard fluid and electrolyte management |
| legal | String | [[USLegal:Prescription only|Rx-only]] for parenteral formulations; OTC for oral, nasal, and many nebulizer products |
